A detailed history of Dnca Finance transactions in Medtronic PLC stock. As of the latest transaction made, Dnca Finance holds 95,550 shares of MDT stock, worth $8.67 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
95,550
Previous 81,550 17.17%
Holding current value
$8.67 Million
Previous $7.33 Billion 13.66%
% of portfolio
0.64%
Previous 0.61%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$80.68 - $88.86 $1.13 Million - $1.24 Million
14,000 Added 17.17%
95,550 $8.33 Billion
Q1 2025

May 14, 2025

SELL
$79.84 - $94.5 $4.81 Million - $5.69 Million
-60,200 Reduced 42.47%
81,550 $7.33 Billion
Q4 2024

Feb 13, 2025

BUY
$79.61 - $92.24 $3.45 Million - $4 Million
43,391 Added 44.11%
141,750 $11.3 Billion
Q3 2024

Nov 13, 2024

SELL
$76.84 - $91.03 $5.35 Million - $6.34 Million
-69,641 Reduced 41.45%
98,359 $8.86 Billion
Q2 2024

Jul 15, 2024

BUY
$78.71 - $87.02 $13.2 Million - $14.6 Million
168,000 New
168,000 $13.2 Billion

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $121B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Dnca Finance Portfolio

Follow Dnca Finance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dnca Finance, based on Form 13F filings with the SEC.

News

Stay updated on Dnca Finance with notifications on news.